Does Amlodipine Make You Cough? The Real Answer

Amlodipine is not known to cause the persistent dry cough that plagues users of another common class of blood pressure drugs, ACE inhibitors. In clinical trials, cough has been reported in fewer than one in a hundred people taking amlodipine, and even those reports are difficult to separate from background cough rates in the general population. The confusion between the two drug classes is widespread, though, and there are a few indirect pathways by which amlodipine can contribute to throat irritation or coughing that are worth understanding.

Why Blood Pressure Medications Get Blamed for Coughs

The drug class most strongly associated with cough is ACE inhibitors, which include medications like lisinopril, enalapril, and ramipril. Somewhere between 5% and 35% of people taking an ACE inhibitor develop a dry, tickling cough that does not go away on its own while the drug is being taken. The cough happens because ACE inhibitors block the enzyme that normally breaks down certain chemicals in the airways. When that enzyme is inhibited, substances like bradykinin and substance P build up in the upper airway and lungs, irritating the tissue and triggering the cough reflex.¹ Prostaglandins, whose production is stimulated by bradykinin, may amplify the irritation further.

Amlodipine belongs to an entirely different drug class: calcium channel blockers. These medications lower blood pressure by relaxing blood vessel walls, and they have no effect on the enzyme that degrades bradykinin. There is no pharmacological reason for amlodipine to cause the same kind of cough. Yet many people taking amlodipine were previously on an ACE inhibitor, or they are taking both medications together. When a cough develops in that setting, amlodipine is an easy suspect, even though the ACE inhibitor is almost always the real culprit.

How Common Is Cough With Amlodipine in Clinical Trials

In head-to-head trials comparing antihypertensive agents, cough rates in the amlodipine groups have consistently been very low. In one trial that directly compared cough among patients assigned to different blood pressure drugs, only two out of sixty patients taking amlodipine reported cough, a rate dramatically lower than what was observed in the ACE inhibitor group. In a larger tolerability study, cough was classified as rare, occurring in fewer than one percent of amlodipine users. These numbers are essentially no different from what you would expect in any group of adults regardless of what medication they are taking; background cough from colds, allergies, and postnasal drip is that common.

A pharmacovigilance study that analyzed reports to the FDA’s adverse event reporting system found that amlodipine’s most notable risks involve peripheral edema (swollen ankles), low blood pressure episodes, and shortness of breath.² Cough did not emerge as a prominent safety signal. That does not mean no one has ever reported a cough while taking amlodipine, because voluntary reporting systems capture every symptom a patient experiences regardless of whether the drug caused it. It means the pattern analysts look for, where the number of reports significantly exceeds what would be expected by chance, was not present for cough.

Indirect Ways Amlodipine Can Make You Cough

Even though amlodipine does not cause cough through the same mechanism as ACE inhibitors, it can contribute to coughing through a back door: acid reflux. All calcium channel blockers relax smooth muscle, and that includes the muscle at the junction between the esophagus and the stomach. When that sphincter relaxes inappropriately, stomach acid can creep upward. In a study of patients with pre-existing gastrointestinal symptoms, roughly 45% reported worsening reflux during calcium channel blocker therapy, and amlodipine stood out as the worst offender in the group, with over 60% of its users experiencing more frequent or more severe reflux symptoms compared to about 12% for diltiazem.³

This matters because acid reflux is one of the top three causes of chronic cough. Stomach acid that reaches the lower esophagus or throat can trigger a cough reflex even when the person does not feel classic heartburn. So while amlodipine is not irritating the airways directly the way an ACE inhibitor would, it can worsen reflux, and the reflux can cause a cough. If you have a history of heartburn, GERD, or acid-related symptoms and you develop a cough after starting amlodipine, the reflux connection is worth exploring with your doctor. An antacid trial or adjusting the timing of meals relative to the medication may resolve it.

Separately, amlodipine has been linked to shortness of breath in some patients, particularly in the context of fluid retention and ankle swelling. This is not the same as cough, but patients sometimes describe chest tightness or labored breathing in ways that overlap with a coughing sensation. If the issue is fluid-related, it tends to come with visible swelling in the legs or feet and may respond to dose adjustment or the addition of a diuretic.

The Nocebo Effect and Cough Expectations

There is another layer to this question that has nothing to do with pharmacology. When people start a new medication and expect a particular side effect, they are more likely to experience and report it. This is the nocebo effect, essentially the evil twin of the placebo effect. Research on antihypertensive medications has found that expectation and nocebo responses contribute to cough reporting among patients starting new blood pressure drugs.⁴

This is particularly relevant for people who were previously on an ACE inhibitor and developed a cough. If they are switched to amlodipine, the memory of the cough and the general association between “blood pressure pill” and “cough” can prime them to notice throat sensations they might otherwise ignore. A dry throat, a minor post-nasal drip, seasonal allergies, even the tail end of the ACE inhibitor cough that has not fully resolved yet can all be interpreted as a side effect of the new medication. Controlled trials consistently find that cough rates in the amlodipine group are not meaningfully different from those in the placebo group, which is about as strong an exoneration as pharmacology can offer.

If You Switched From an ACE Inhibitor, the Cough Might Still Be Lingering

This is one of the most commonly overlooked explanations. ACE inhibitor cough does not stop the moment you take the last pill. After stopping an ACE inhibitor, the cough typically takes one to four weeks to resolve, but in some people it can persist for up to three months.⁵ The reason is that the buildup of bradykinin and related chemicals in the airways takes time to clear, and the irritated airway tissue needs time to calm down.

If your doctor switched you from, say, lisinopril to amlodipine, and the cough continued for several weeks afterward, it is natural to wonder if the new drug is the problem. But the timeline alone does not prove causation. The real test is whether the cough eventually fades. If it disappears within a few months of the switch, the ACE inhibitor was almost certainly responsible. If it persists well beyond three months, other causes such as reflux, asthma, postnasal drip, or an unrelated respiratory condition should be investigated.

Who Is Most Likely to Develop ACE Inhibitor Cough

Understanding who is most susceptible to ACE inhibitor cough helps explain why certain groups of patients end up on amlodipine in the first place and why they may arrive with residual concerns about coughing. Women are more commonly affected than men, and there are meaningful differences across racial and ethnic groups. In one study, Black patients were about four times more likely to develop a cough severe enough to require stopping their ACE inhibitor compared to other patients.⁶ The discontinuation rate was about 10 per 100 patients among Black subjects compared to roughly 2 per 100 among others. Researchers have suggested that genetic variation in the ACE gene may play a role, though the exact biological mechanism behind this disparity has not been fully worked out.

Because of this higher susceptibility, Black patients and women are disproportionately switched from ACE inhibitors to alternatives like amlodipine or ARBs (angiotensin receptor blockers, a class that blocks a different part of the same blood pressure system without affecting bradykinin). If you are in one of these groups and developed a cough on an ACE inhibitor, it is especially important to know that amlodipine was likely chosen precisely because it avoids the cough problem, not because all blood pressure drugs carry that risk.

When Amlodipine and ACE Inhibitors Are Used Together

Many people take amlodipine alongside an ACE inhibitor as a combination therapy. The two drugs lower blood pressure through complementary mechanisms, and the combination is generally well tolerated with evidence that it decreases cardiovascular and kidney disease risk.⁷ In this scenario, if a cough develops, the ACE inhibitor is the first suspect. Your doctor will likely consider whether to lower the ACE inhibitor dose, switch the ACE inhibitor to an ARB while keeping the amlodipine, or adjust the regimen in some other way.

It is worth asking your pharmacist or doctor whether any of your medications contain an ACE inhibitor, because combination pills sometimes bundle two drugs under a single brand name that does not obviously reveal what is inside. A pill marketed for blood pressure could contain both amlodipine and an ACE inhibitor like benazepril. If you are coughing and only see “amlodipine” on your bottle, check whether the full name includes a second ingredient.

Rare Pulmonary Events in the Medical Literature

For completeness, there are isolated case reports in the medical literature linking amlodipine to serious lung reactions. One published case involved a patient who developed organizing pneumonia, a type of inflammatory lung condition, following an amlodipine overdose. Bronchoscopy confirmed the diagnosis, and the condition resolved completely within six months of stopping the drug.⁸ This is the kind of finding that belongs in a medical journal rather than on a worry list, because it involved a massive overdose rather than normal therapeutic doses, and the event is essentially unreported outside of that context.

Drug-induced lung injury is a recognized phenomenon across many medication classes, but with amlodipine at standard doses, pulmonary complications are vanishingly rare. If you are taking a normal prescribed dose and develop a sudden, severe cough with fever or worsening shortness of breath, that warrants urgent medical attention, but the differential diagnosis would include pneumonia, heart failure exacerbation, or pulmonary embolism long before anyone would suspect the amlodipine.

Practical Steps if You Are Coughing on Amlodipine

If you have developed a new or persistent cough since starting amlodipine, a few practical steps can help narrow down the cause:

Check your full medication list. Are you also taking an ACE inhibitor, either as a separate pill or as part of a combination tablet? If so, the ACE inhibitor is the most likely culprit.
Consider the timeline. If you recently stopped an ACE inhibitor, the cough may still be resolving. Give it up to three months before concluding the new medication is responsible.
Think about reflux. If you have a history of heartburn or the cough is worse after eating, lying down, or in the morning, reflux-related cough is a strong possibility. Amlodipine can worsen reflux in people already prone to it.
Rule out the usual suspects. Postnasal drip from allergies, mild asthma that has not been diagnosed, and seasonal respiratory infections collectively account for most chronic coughs in adults. These have nothing to do with your blood pressure medication.
Do not stop the medication on your own. Uncontrolled blood pressure carries real risks. Talk to your prescriber about the cough so they can evaluate it properly and make an informed switch if needed.

How Amlodipine Compares With Other Calcium Channel Blockers

Amlodipine is the most commonly prescribed calcium channel blocker, but it is not the only one. Others in the class include nifedipine, felodipine, and diltiazem. None of these drugs cause cough through the bradykinin pathway. Where they do differ is in their tendency to relax the esophageal sphincter and worsen reflux. As noted in the reflux study, diltiazem was substantially less likely to aggravate gastrointestinal symptoms than amlodipine was.³ So if reflux-related cough turns out to be the issue and your doctor wants to keep you on a calcium channel blocker, switching within the class to a non-dihydropyridine option like diltiazem could help. That said, diltiazem has its own considerations, including effects on heart rate, so the decision is not as simple as picking the one with less reflux.

ARBs, which include drugs like losartan, valsartan, and candesartan, are another common alternative when ACE inhibitor cough is the driving concern. They work on the same blood pressure system as ACE inhibitors but do not block the enzyme responsible for bradykinin breakdown, so cough rates with ARBs are comparable to placebo. If you have been bouncing between medications trying to escape a cough, an ARB is often the cleanest swap from an ACE inhibitor, while amlodipine can be added on top if more blood pressure control is needed.